WEBINARS
Our webinars allow users to learn from experts and earn continuing education credits on industry topics, progress in research, services available, and more.
Show More
-
AUG 29, 2023 | 7:00 AMC.E. CREDITS
Spatialomics leverages multiplex imaging to achieve translational profiling of tissue specimens by assessing the relative spatial orientations of biological structures with RNA and protein e... -
AUG 24, 2023 | 8:30 PMC.E. CREDITS
When building your own infectious disease molecular panels there are many paths to consider. In this interview, we ask Marcus Cognetti and Dr. Ari Frenkel what approach is required to create...
-
AUG 17, 2023 | 8:00 AMC.E. CREDITS
Globally millions of individuals get sick, hundreds of thousands are hospitalized, and tens of thousands die from respiratory viruses such as Influenza and Respiratory Syncytial Virus (RSV)...
-
AUG 10, 2023 | 8:00 AMC.E. CREDITS
Antibody therapeutics is a fast-growing market boosted by developments in bispecific antibodies and in newly emerging tetra-specific antibodies. With the ability to recruit a combination of...
-
AUG 01, 2023 | 10:00 PMC.E. CREDITS
Stem cells have the capability to develop into any specialized cell type, which makes them a valuable resource in research and regenerative medicine. Differentiated stem cell models provide...
-
AUG 01, 2023 | 10:00 AMC.E. CREDITS
Human cytomegalovirus (CMV) infection is common and usually results in a mild, non-specific illness in otherwise healthy individuals followed by asymptomatic latency. However, congenital CMV...
-
AUG 01, 2023 | 9:00 AMC.E. CREDITS
Testing for abnormal immunoglobulins was based previously on serum electrophoresis and immunofixation only. In the last years, however, free light chain (FLC) testing in serum became one imp...
-
JUL 26, 2023 | 4:45 PMC.E. CREDITS
Inefficient knock-in of transgene cargos limits the potential of cell-based medicines. In this study, we used a CRISPR nuclease that targets a site within an exon of an essential gene and de...
JUL 26, 2023 | 4:05 PM
C.E. CREDITS
Employing a metagenomic search, we identified a family of miniature CRISPR-Cas type V-L systems capable of RNA-guided dsDNA target cleavage without a tracrRNA. A bacterial depletion screen r...
JUL 26, 2023 | 3:10 PM
C.E. CREDITS
Cell-based immunotherapy has become the new-generation cancer medicine, and “off-the-shelf” cell products that can be manufactured at large scale and distributed readily to treat...
JUL 26, 2023 | 2:30 PM
C.E. CREDITS
Phosphorylation of α-synuclein at the Serine-129 site (α-syn Ser129P) is an established pathologic hallmark of synucleinopathies and a therapeutic target. In physiologic states,...
